Cost-effectiveness of measles and rubella elimination in low-income and middle-income countries.

ABSTRACT:

Background

Since 2000, the incidence of measles and rubella has declined as measles-rubella (MR) vaccine coverage increased due to intensified routine immunisation (RI) and supplementary immunisation activities (SIAs). The World Health Assembly commissioned a feasibility assessment of eliminating measles and rubella. The objective of this paper is to present the findings of cost-effectiveness analysis (CEA) of ramping up MR vaccination with a goal of eliminating transmission in every country.

Methods

We used projections of impact of routine and SIAs during 2018-2047 for four scenarios of ramping up MR vaccination. These were combined with economic parameters to estimate costs and disability-adjusted life years averted under each scenario. Data from the literature were used f

SUBMITTER: Levin A 

PROVIDER: S-EPMC10335502 | biostudies-literature | 2023 Jul

REPOSITORIES: biostudies-literature